IL6 and systemic sclerosis: These clinical data were corroborated by the measurement of collagen content in skin, significantly lower in mice treated with WT, IL1RA−/−, or IL6−/−-MSC compared with HOCl-SSc mice, while no significant effect was noted for iNOS−/−-MSC-treated mice (Figure 1C).